Le Lézard

News by subject: HEALTH

14 december 2022

07:35
Avicanna Inc. ("Avicanna" or the "Company") , a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it will be initiating an...

07:30
Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it will host its Q4 and Full Year Fiscal 2022 earnings conference call and audio webcast on...


13 december 2022

10:15
Alcohol was involved in more medical emergencies that sent young people to hospital emergency departments (EDs) than cannabis or opioids, according to a new study of 4,634 cases in three Canadian communities. In a four-year study of EDs in...

08:25
Glenora Park, Edmonton's newest and most prestigious retirement living residence, is open and welcoming new residents. ONE Properties, a privately owned, integrated real estate investment firm that develops and manages a range of high-quality...

07:00
MCI Onehealth Technologies Inc. ("MCI" or the "Company") , a clinician-led...


12 december 2022

11:40
Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address addiction and mental health, is pleased to announce...

08:30
ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today findings from a safety and efficacy retrospective analysis comparing outcomes of patients treated with ECT-001 (UM171-expanded) Cell Therapy...

08:00
What: Ontario Health Coalition leader Natalie Mehra will be available to respond to the Ford government's denial and downplaying of the hospital crisis and failure to address it outside the Queen's Park south facing main entrance on Monday December...


9 december 2022

16:20
What: Ontario Health Coalition leader Natalie Mehra will be available to respond to the Ford government's denial and downplaying of the hospital crisis and failure to address it outside the Queen's Park south facing main entrance on Monday December...

11:05
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®) (STO:SOBI), announced today that...

08:00
The Ontario Health Coalition has tracked hospital cuts, closures, service closures and overcrowding for more than two decades and are experts in the history and scale of these events. The Coalition has never seen the crisis in our public hospitals...


8 december 2022

17:00
Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce that George Tziras, Chief Executive Officer and Dr. Carol...

07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce new proof of concept data demonstrating, in a...


7 december 2022

16:45
The Ontario Health Coalition has tracked hospital cuts, closures, service closures and overcrowding for more than two decades and are experts in the history and scale of these events. The Coalition has never seen the crisis in our public hospitals...

16:30
The Sabin Vaccine Institute today honored two extraordinary scientists for their breakthrough vaccine research that changed the course of the COVID-19 pandemic, advanced public health, and saved countless lives. The 2022 Albert B. Sabin Gold Medal...

07:00
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that treatment with...


6 december 2022

11:35
A new study by Calgon Carbon Corporation ("Calgon Carbon"), a wholly owned subsidiary of Kuraray Co., Ltd. (TYO: 3405) ("Kuraray"), has provided a definitive response to a persistent question about the fate of PFAS during reactivation of activated...

08:00
Novel antibody, TB006, demonstrated improvements in cognition and function and was well tolerated in a one-month Phase 1b/2 trial in mild to severe Alzheimer's disease (AD) patientsTB006 also demonstrated improvements in PET and MR imaging,...


5 december 2022

16:30
InterCure Ltd. (dba Canndoc) ("InterCure" or the "Company") is pleased to announce the withdrawal of a class action lawsuit against it (the "Regenera Lawsuit"). The Regenera Lawsuit was described in the Company's press release dated May 26, 2020...

13:20
Sweegen announced its strategic investment and partnership snapshot ahead of the FI Europe 2022, where it will exhibit zero sugar solutions in immersive food experiences, displaying consumers' favorite foods and beverages with zero sugar solutions in...

09:30
Nymox Pharmaceutical Corporation (the "Company") is pleased to announce today that a new formal submission has been made by the Company in Europe for Fexapotide Triflutate for the treatment of benign prostatic hyperplasia (BPH). The trademarked name...

09:00
The Canadian Association of Suicide Prevention (CASP) and the Canadian Suicide Prevention Coordinators Network (CSPCN) are pleased to announce that they have recently joined forces through a partnership that will strengthen collaborations among the...

08:00
Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch Spectronaut 17 today at the HUPO 2022 World Congress in Cancun, Mexico. Since its first release in 2003, Spectronaut has...

07:30
Biogen Inc. announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for review of tofersen, an investigational drug for the treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis...

07:00
Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that the United States Food and Drug Administration ("U.S. FDA") has granted Orphan Drug Designation...


2 december 2022

14:15
Toronto ? When the world was largely shut down during the onset of the COVID-19 pandemic, the leadership behind Creative Destruction Lab (CDL) at the University of Toronto's Rotman School of Management began to think about how to redeploy their...

14:00
Celebrated every year since 1992 at the initiative of the United Nations (UN), December 3 is the International Day of Persons with Disabilities. It aims to promote understanding of disability issues and mobilize support for the dignity, rights and...


1 december 2022

15:55
A recent study out of McGill University states that melanoma, the most dangerous form of skin cancer that has the ability to spread to other organs, is on the rise in Canada and doctors believe it is time to bring awareness to this disturbing trend....

09:00
Novan, Inc. ("the Company" or "Novan") , today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will participate in a panel discussion titled, "Distraction or Destruction?: What's New/Next in the Industry," at the...


30 november 2022

17:45
REVIVE THERAPEUTICS LTD. ("Revive" or the "Company") is pleased to announce that it is arranging a private placement of a minimum of $3 million and up to $5 million of units (each, a "Unit"), at a price of $0.15 per Unit; (the "Offering"). The...

07:30
Titan Medical Inc. ("Titan" or the "Company"), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that its Board of Directors (or the "Board"), in consultation with its financial and legal advisors,...

07:30
Irwin Naturals Inc.  (FRA: 97X) ("Irwin" or the "Company") announced today it reached a binding, arms-length, agreement to acquire Serenity Health, LLC in Louisville, Kentucky, on November 25, 2022. The move continues Irwin's national ketamine...


29 november 2022

18:45
Theralase® Technologies Inc. ("Theralase" or the "Company") , a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDC") and their associated drug formulations intended to...

15:25
Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the...

09:10
Revera is building on its strong commitment to Habitat for Humanity Canada with a donation of $115,000 from the proceeds of its annual charity golf tournament, fundraising from events held at its retirement residences and long term care homes, and...

07:30
Purpose Investments Inc. ("Purpose") is pleased to announce that the Purpose Healthcare Innovation Yield Fund has elected to increase its annual distribution target from 5% to 8%, which will be paid in monthly distributions at $0.133 per unit,...

07:00
MARKHAM, Ontario ? November 29, 2022 ? In the sports world, GOAT stands for the ?Greatest Of All Time' ? think Donovan Bailey, Wayne Gretzky and Christine Sinclair. But this Giving Tuesday (November 29), Children Believe, a charity that annually...


28 november 2022

10:00
November 28, 2022 Philips introduces next-generation Advanced Visualization Workspace, including new cardiac MR Suite with new workflow and user interface, new AI powered CT ASPECT Scoring, and enhanced CT Liver Analysis applications [1]New...

09:00
November 28, 2022 New Ultrasound Compact System 5000 Series delivers premium image quality needed to aid in a confident diagnosis in a portable unit Compatibility with Philips ultrasound systems Affiniti and EPIQ transducers, user interface,...

08:00
Providence Therapeutics Holdings Inc. ("Providence") today announced that Aleksandra Pastrak, M.D., Ph.D., chief medical officer of Providence Therapeutics, will deliver a...

06:35
AXS-05 statistically significantly delayed time to relapse of Alzheimer's disease agitation versus placebo (p=0.014, primary endpoint) AXS-05 statistically significantly prevented relapse of Alzheimer's disease agitation versus placebo (p=0.018,...


27 november 2022

09:00
November 27, 2022 Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency to address workforce shortages and staff burnout and enable a clear care pathway for every patient...


24 november 2022

10:55
Pizza Nova announces the start of a two-year partnership with SickKids Foundation. To help share the love this holiday season, the Toronto-based pizza company has created a limited-edition vespa ornament to honour its Italian roots, proceeds of which...

09:25
The lawyers and staff of Thomson Rogers are proud to show our support for people living with spinal cord injuries, as Platinum sponsor of Spinal Cord Injury Ontario's #peeitforward campaign. The #peeitforward campaign aims to raise awareness and...

09:00
The ALS Society of Canada (ALS Canada) and Brain Canada are powering innovative discoveries and treatments for amyotrophic lateral sclerosis (ALS) through exciting new research funding. Together they are investing a total of $390,000 to support three...

08:00
In early 2022, TIRF partnered with Diageo North America to establish the Impaired Driving Coalition of Canada (IDCC) and develop a National Action Plan aimed at preventing impaired driving. The IDCC combines the knowledge and expertise of diverse...

07:30
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the...


23 november 2022

19:15
Advanced Home Care Solutions (AHCS) reveals its robust expansion plans. This initiative stems from their vision to enable a broader audience to gain access to health care professionals like HCA's, LPN's and RN's. AHCS intends to increase its Canadian...


22 november 2022

10:00
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds the decision from the U.S Food and Drug Administration (FDA) to approve Provention Bio's teplizumab. Teplizumab is the first therapy available to delay the...

08:00
LexaGene Holdings, Inc.,  ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing, is pleased to announce the completion of a validation study with a major...